tranexamic acid has been researched along with Dermatitis, Atopic in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
López González, G | 1 |
Parra, C | 1 |
Billene, RN | 1 |
Ortíz Medina, AH | 1 |
Grinberg, AJ | 1 |
1 other study available for tranexamic acid and Dermatitis, Atopic
Article | Year |
---|---|
[Actinic prurigo. Treatment with antifibribolytics].
Topics: Adolescent; Adult; Aminocaproic Acid; Antifibrinolytic Agents; Dermatitis, Atopic; Drug Evaluation; | 1979 |